Cambridge Epigenetix
Leading the epigenomics revolution through groundbreaking research tools
Total raised
€24M
€24,090,909
Funding rounds
2
Investors
5
distinct backers
Active since
2014-09
latest 2016-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood21
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 14y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-03-01 | Series B | €19M | GV (Google Ventures),New Science Ventures,Sequoia Capital,Syncona Partners | View deal → |
| 2014-10-01 | Series A | €5.0M | Cambridge Enterprise,New Science Ventures,Syncona Partners | View deal → |